Literature DB >> 30561106

Exosome-encapsulated microRNA-4525, microRNA-451a and microRNA-21 in portal vein blood is a high-sensitive liquid biomarker for the selection of high-risk pancreatic ductal adenocarcinoma patients.

Sachiyo Kawamura1, Hisae Iinuma1, Keita Wada1, Kunihiko Takahashi1, Shunryo Minezaki1, Masahiko Kainuma1, Makoto Shibuya1, Fumihiko Miura1, Keiji Sano1.   

Abstract

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with poor prognosis. This is due to late diagnosis and lack of reliable prognostic biomarkers. In this study, we focused on exosomal microRNA (miRNA) in portal vein blood (PVB) as a potential biomarker to identify patients at high-risk for recurrence and poor postoperative outcome.
METHODS: Exosomal miR-4525, miR-451a and miR-21 expressions were assessed using PVB and peripheral blood (PB) collected from 55 PDAC patients during curative pancreatectomy. Correlation between the miRNA expressions and clinical outcomes, and target genes expressions was investigated.
RESULTS: Exosomal miR-4525, miR-451a and miR-21 levels were upregulated in PVB, which were higher than those in the PB. High expression of miR-4525, miR-451a and miR-21 in PVB was associated with recurrence with a higher sensitivity, specificity, and accuracy than that in PB. Cox regression analysis showed miR-4525, miR-451a and miR-21 levels in PVB were independent prognostic factors for overall survival and disease-free survival. There was a negative correlation between the expressions of miR-4525 and MEN1 mRNA, miR-451a and CAB39 mRNA, and t miR-21 and PDCD4 mRNA.
CONCLUSIONS: miR-4525, miR-451a and miR-21 in PVB are potential biomarkers identifying patients at high-risk for recurrence and poor survival in resected PDAC patients.
© 2018 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Exosome microRNA; Liquid biomarker; Pancreatic ductal adenocarcinoma; Portal vein blood; Recurrence

Mesh:

Substances:

Year:  2019        PMID: 30561106     DOI: 10.1002/jhbp.601

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  18 in total

1.  Profiling of Serum Extracellular Vesicles Reveals miRNA-4525 as a Potential Biomarker for Advanced Renal Cell Carcinoma.

Authors:  Yuka Muramatsu-Maekawa; Kyojiro Kawakami; Yasunori Fujita; Manabu Takai; Daiki Kato; Keita Nakane; Taku Kato; Tomohiro Tsuchiya; Takuya Koie; Yuri Miura; Masafumi Ito; Kosuke Mizutani
Journal:  Cancer Genomics Proteomics       Date:  2021 May-Jun       Impact factor: 4.069

2.  Prognostic value of microRNAs in pancreatic cancer: a meta-analysis.

Authors:  Fei Zhao; Chao Wei; Meng-Ying Cui; Qiang-Qiang Xia; Shuai-Bin Wang; Yue Zhang
Journal:  Aging (Albany NY)       Date:  2020-05-18       Impact factor: 5.682

Review 3.  Isolation and characterization of exosomes for cancer research.

Authors:  Le Zhu; Hao-Ting Sun; Shun Wang; Sheng-Lin Huang; Yan Zheng; Chao-Qun Wang; Bei-Yuan Hu; Wei Qin; Tian-Tian Zou; Yan Fu; Xiao-Tian Shen; Wen-Wei Zhu; Yan Geng; Lu Lu; Hu-Liang Jia; Lun-Xiu Qin; Qiong-Zhu Dong
Journal:  J Hematol Oncol       Date:  2020-11-10       Impact factor: 17.388

4.  Plasma Extracellular Vesicle Characteristics Correlate with Tumor Differentiation and Predict Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgery with Curative Intent.

Authors:  David Badovinac; Katja Goričar; Hana Zavrtanik; Miha Petrič; Teja Lavrin; Nina Mavec; Vita Dolžan; Aleš Tomažič; Metka Lenassi
Journal:  J Pers Med       Date:  2021-01-28

Review 5.  The Role of Exosomes in Pancreatic Cancer From Bench to Clinical Application: An Updated Review.

Authors:  Kai Chen; Qi Wang; Marko Kornmann; Xiaodong Tian; Yinmo Yang
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

Review 6.  Small extracellular vesicles: from mediating cancer cell metastasis to therapeutic value in pancreatic cancer.

Authors:  Wenjie Zhang; Juan Xing; Tian Liu; Jie Zhang; Zhujiang Dai; Huan Zhang; Daorong Wang; Dong Tang
Journal:  Cell Commun Signal       Date:  2022-01-03       Impact factor: 5.712

Review 7.  The significance of exosomal RNAs in the development, diagnosis, and treatment of pancreatic cancer.

Authors:  Zheng Zhao; Guiping Zhao; Shuyue Yang; Shengtao Zhu; Shutian Zhang; Peng Li
Journal:  Cancer Cell Int       Date:  2021-07-09       Impact factor: 5.722

Review 8.  The involvement of exosomes in the diagnosis and treatment of pancreatic cancer.

Authors:  Abakundana Nsenga Ariston Gabriel; Fang Wang; Qinlian Jiao; Umwali Yvette; Xuemei Yang; Samed Ahmed Al-Ameri; Lutao Du; Yun-Shan Wang; Chuanxin Wang
Journal:  Mol Cancer       Date:  2020-08-27       Impact factor: 27.401

Review 9.  Immuno-Surgical Management of Pancreatic Cancer with Analysis of Cancer Exosomes.

Authors:  Yu Takeda; Shogo Kobayashi; Masatoshi Kitakaze; Daisaku Yamada; Hirofumi Akita; Ayumu Asai; Masamitsu Konno; Takahiro Arai; Toru Kitagawa; Ken Ofusa; Masami Yabumoto; Takaaki Hirotsu; Andrea Vecchione; Masateru Taniguchi; Yuichiro Doki; Hidetoshi Eguchi; Hideshi Ishii
Journal:  Cells       Date:  2020-07-09       Impact factor: 6.600

10.  Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study.

Authors:  Dawei Jiang; Xiangfei Yuan; Jianqi Ni; Lan Shen; Min Cai; Liu Xu
Journal:  Can J Gastroenterol Hepatol       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.